Research on inherited heart conditions in children
Official title: Inherited Cardiac cONditions In Kids: Understanding the Genetics and Outcomes of Paediatric Inherited CardiacConditions
Run by Imperial College London · NCT05158738 · Data updated 2026-11-12
This study is trying to learn more about inherited heart conditions in children and their parents by collecting health information over five years to improve understanding and treatment.
Quick facts
| Study type | Observational |
|---|---|
| Sex | All |
| Enrollment | 300 (estimated) |
| Sponsor | Imperial College London Academic / other |
| Locations | 3 sites (London and 2 other locations) |
| Status | Recruiting |
| Started | September 1, 2022 |
| Main results expected | December 1, 2026 |
| Study ends | December 1, 2026 |
| Registry record updated | March 5, 2025 |
| Trial ID | NCT05158738 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include children under 16 years with a confirmed diagnosis of cardiomyopathy or other rare inherited cardiac conditions, along with their parents.
✕Probably not a fit
Patients over 16 years old or those with significant secondary causes of cardiac dysfunction are unlikely to benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study focuses on children diagnosed with inherited cardiac conditions, particularly cardiomyopathy, and their unaffected parents. Participants will enroll through an online platform called The Heart Hive, where they can upload their health data for research purposes. The study aims to collect genetic and clinical information over a five-year period to identify genetic variants and environmental factors that influence disease progression and treatment response. By analyzing this data, the researchers hope to enhance understanding of these rare conditions and improve patient outcomes.
Why it matters
Potential benefit: If successful, this study could lead to better understanding and management of inherited cardiac conditions in children.
How similar studies have gone: Other studies focusing on genetic factors in inherited cardiac conditions have shown promise, indicating that this approach may yield valuable insights.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Males or females with a confirmed diagnosis of childhood onset (\<16 years) PCM * Males or females with childhood onset (\<16 years) of a rare inherited cardiac condition likely to be a monogenic condition * Capacity for parents to provide informed consent * Genotype negative following local standard diagnostic ICC gene panel * Family members of patients with ICC, both affected and unaffected Exclusion Criteria: * Parents who lack capacity to provide consent on behalf of their children/themselves * Onset over 16 years * Significant teratogen exposure (including maternal diabetes) likely to contribute to cardiac dysfunction (following discussion with Cardiologist) * Significant coronary heart disease likely to contribute to cardiac dysfunction (following discussion with Cardiologist) * Other secondary causes of cardiac dysfunction likely to explain the phenotype of the patient * Patients with a confirmed genetic diagnosis (patients with variants of uncertain significance are not excluded).
Where it's running
-
Royal Brompton Hospital
London, United Kingdom Recruiting -
Great Ormond Street Hospital for Children
London, United Kingdom Recruiting -
Harefield Hospital
Uxbridge, United Kingdom Recruiting
Study contacts
- Principal investigator: James Ware — Imperial College London
- Study coordinator: Katherine Josephs
- Email: k.josephs@imperial.ac.uk
- Phone: 0207 594 9459
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Abnormal menstrual bleeding in women on antithrombotic drugs after heart surgery
This study looks at whether women on blood thinners after heart surgery have abnormal menstrual bleeding and what factors might put some at higher risk.
-
AI-powered ECG to help diagnose and predict outcomes in heart disease
Researchers test an AI-enhanced ECG to help diagnose and predict outcomes for people with cardiovascular diseases.
-
Colchicine for preventing cardiovascular disease in adults with type 2 diabetes
A 24-week study will test whether low-dose colchicine can help protect blood vessels in adults with type 2 diabetes who have not yet developed artery disease, compared with a placebo.
-
Optimised Cardio-Renal Care for CKD and heart disease
This study tests whether a specialised Cardio-Renal Clinic can improve heart and kidney health and quality of life for adults with chronic kidney disease and cardiovascular disease.
-
Inhaled mosliciguat for pulmonary hypertension in interstitial lung disease (PH-ILD) patients
This study tests inhaled mosliciguat versus placebo in people with PH-ILD to see if it helps with their condition.
-
One-stop photon-counting CT for patients after PCI
This study tests a single CT exam using photon-counting technology to image the heart after stent placement in people who have had PCI.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.